This spotlight session will feature two companies working on cell therapy for solid tumors to explore their approaches and the outlook for the future .
Chair:
Alexander Pasteur, Ph.D., Partner, F-Prime Capital
Speakers:
Usman Azam, M.D., President and CEO, Tmunity Therapeutics
Kimberly Freeman, VP, Commercial, Adaptimmune
![](https://i.ytimg.com/vi/hONlozfTXBY/maxresdefault.jpg)